stock

Dexcom Inc (DXCM)

Share

Stay up to date

DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.

Financial Statements

Key Info

  • Industry: Surgical and Medical Instrument Manufacturing
  • Sector: Manufacturing
  • CEO Name: Kevin Sayer

Key Statistics

  • Stock Price: $511.6
  • Dividend Yield: 0%
  • Market Capitalization: $50,547,118,013
  • Shares Outstanding: 97,389,538
  • Number of Employees: 5,500
  • Trailing 12-Month EPS: $1.55
  • Trailing 12-Month DPS: $0
  • Payout Ratio: 0.0%

Important Dates

  • Next Earnings Date: 2022-04-28
  • Next Ex-Dividend Date:

Price Trends

  • Current Stock Price: $511.6
  • 52-week high: $659.45
  • 52-week low: $318.45
  • 200-day moving average: $511.93
  • 50-day moving average: $430.04

Performance

  • 1-Month Price Return: 26.2%
  • 3-Month Price Return: -4.1%
  • 6-Month Price Return: -4.9%
  • 1-Year Price Return: 49.5%
  • 2-Year Price Return: 86.7%
  • 5-Year Price Return: 510.4%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast